John C.M. Farquhar Sells 38,900 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 38,900 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the completion of the transaction, the chief executive officer owned 457,935 shares in the company, valued at $16,027,725. This represents a 7.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.
• On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $29.12, for a total transaction of $657,005.44.
• On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $26.72, for a total transaction of $602,856.64.

Heartflow Price Performance

NASDAQ HTFL opened at $35.68 on Friday. The company has a fifty day moving average of $30.69 and a two-hundred day moving average of $28.60. The company has a market capitalization of $3.08 billion and a PE ratio of -11.47. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $41.22.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The firm had revenue of $52.59 million for the quarter. The business’s revenue was up 41.3% on a year-over-year basis. On average, research analysts expect that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on HTFL. Canaccord Genuity Group decreased their price objective on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a report on Friday, May 15th. Piper Sandler reiterated an “overweight” rating on shares of Heartflow in a research report on Thursday, June 11th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, June 12th. JPMorgan Chase & Co. dropped their price objective on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research note on Thursday, March 19th. Finally, William Blair assumed coverage on shares of Heartflow in a report on Monday, May 4th. They issued an “outperform” rating for the company. Six equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $37.00.

Institutional Investors Weigh In On Heartflow

A number of institutional investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP raised its stake in shares of Heartflow by 20.8% during the 4th quarter. Wellington Management Group LLP now owns 5,894,070 shares of the company’s stock worth $171,812,000 after buying an additional 1,014,006 shares in the last quarter. Bamco Inc. NY grew its holdings in Heartflow by 86.2% during the fourth quarter. Bamco Inc. NY now owns 2,303,877 shares of the company’s stock worth $67,158,000 after acquiring an additional 1,066,371 shares during the period. Janus Henderson Group PLC raised its position in Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after acquiring an additional 1,315,416 shares in the last quarter. Schusterman Interests LLC purchased a new position in Heartflow in the third quarter worth $65,274,000. Finally, Capricorn Investment Group LLC acquired a new stake in Heartflow in the fourth quarter valued at $48,178,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.